23rd November 2021 | Pharma Updates
India's drug regulator approves Jardiance
This drug is used to reduce the risk of cardiovascular-related death in patients with type-II diabetes and cardiovascular diseases.
Gas-O-Fast launches its multilingual TV commercial
The new ad will be aired across social media and other digital platforms.
Bengaluru to host 5th edition of Indian Pharma Fair
This expo will be held at Manpho Convention Center, Bengaluru from Nov 27-28.
United States and India discuss intellectual property led solutions to a global pandemic
The Global Innovation Policy Center and US-India Business Council, in partnership with FICCI, invited government and industry leaders for the 4th annual IP Dialogue.
Cabinet secretaryy-led panel to take call on more allocation to production-linked incentive pharma
The department has urged the top government panel to provide additional funds of almost Rs 3000 cr under the scheme for medicines.
Vifor Pharma buys Sanifit Therapeutics and Inositec AG
Through these acquisitions, Vifor Pharma will be able to serve a continuum of vascular calcification disorders at all stages of chronic kidney disease .
Sagent Pharmaceuticals recalls levetiracetam
The US-based company is recalling four lots of injectable levetiracetam, which is used in a few types of seizures.
You must be logged in to post a comment.